Technology

CohBar

$1.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+4.85%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CohBar and other stocks, options, and ETFs commission-free!

About CWBR

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA. The listed name for CWBR is CohBar, Inc. Common Stock.

CEO
Steven B. Engle
Employees
13
Headquarters
Menlo Park, California
Founded
2007
Market Cap
96.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
582.44K
High Today
$1.80
Low Today
$1.59
Open Price
$1.64
Volume
1.05M
52 Week High
$4.25
52 Week Low
$0.85

Collections

CWBR Earnings

-$0.10
-$0.07
-$0.03
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

RFM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure